Netherlands biotech startup Cradle announced it has raised $24 million in Series A funding, taking its total funding to $33 million.
The company uses generative AI to help scientists design and engineer proteins, building easy-to-use web-based software that any team of scientists and experimentalists can use without help from a bioinformatician or machine learning engineer.
The software helps break down traditional data roadblocks that challenge biotechnology companies to make their data available to use Generative AI and ML tools that will accelerate R&D pipelines.